Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery

被引:0
|
作者
A. Wildfeuer
J. Mallwitz
H. Gotthardt
E. Hille
H. Gruber
G. Dahmen
G. Pfaff
G. Göbel
机构
[1] Research and Development,
[2] Pfizer/Mack,undefined
[3] Allgemeines Krankenhaus,undefined
[4] Bambek,undefined
[5] Orthopädische Universitätsklinik Eppendorf,undefined
[6] Klinische Forschung,undefined
[7] Pfizer GmbH,undefined
来源
Infection | 1997年 / 25卷
关键词
Public Health; Internal Medicine; Infectious Disease; General Practice; Ampicillin;
D O I
暂无
中图分类号
学科分类号
摘要
As perioperative prophylaxis for major orthopedic operations 81 patients were given the fixed combination of ampicillin (1 g)/ sulbactam (0.5 g) or cefotiam (2 g) as short infusions. The three β-lactams were rapidly distributed into the different tissues and their pharmacokinetic profiles were found to be very similar. It was noteworthy that ampicillin, sulbactam and cefotiam penetrated within minutes, not only into skin, fat and muscles, but also into bone. Thus 0.25 h after starting the infusion the following mean concentrations were measured in bone: 21.8±10.5 mg/kg ampicillin, 4.9±2.2 mg/kg sulbactam and 19.4±10.6 mg/kg cefotiam. For a period of at least 2 h the concentrations measured in serum and in the different tissues affected by the operation (skin, fat, muscle, bone) were above the MICs for pathogens which are involved in postoperative wound infections. On the basis of pharmacokinetic data, ampicillin/sulbactam and cefotiam seem about equally suitable for perioperative prophylaxis in major orthopedic operations.
引用
收藏
页码:258 / 262
页数:4
相关论文
共 50 条
  • [21] Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients
    Setiawan, Eko
    Cotta, Menino Osbert
    Abdul-Aziz, Mohd-Hafiz
    Widjanarko, Doddy
    Sosilya, Hernycane
    Lukas, Dwi Lily
    Wallis, Steven C.
    Parker, Suzanne
    Roberts, Jason A.
    CLINICAL PHARMACOKINETICS, 2023, 62 (04) : 573 - 586
  • [22] AMPICILLIN-SULBACTAM VERSUS CEFOXITIN FOR PROPHYLAXIS IN HIGH-RISK PATIENTS UNDERGOING ABDOMINAL-SURGERY
    PALADINO, JA
    RAINSTEIN, MA
    SERRIANNE, DJ
    PRZYLUCKI, JE
    WELAGE, LS
    COLLURA, ML
    SCHENTAG, JJ
    PHARMACOTHERAPY, 1994, 14 (06): : 734 - 739
  • [23] Pharmacokinetics of an ampicillin/sulbactam (2:1) combination in rabbits
    Escudero, E
    Vicente, MS
    Serrano, JM
    Cárceles, CM
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (04) : 259 - 264
  • [24] CONCENTRATIONS OF AMPICILLIN PLUS SULBACTAM IN SERUM AND INTESTINAL-MUCOSA AND EFFECTS ON THE COLONIC MICROFLORA IN PATIENTS UNDERGOING COLORECTAL SURGERY
    KAGER, L
    MALMBORG, AS
    SJOSTEDT, S
    NORD, CE
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) : 559 - 563
  • [25] PHARMACOKINETICS OF CEFOTIAM IN PATIENTS WITH IMPAIRED RENAL-FUNCTION AND IN THOSE UNDERGOING HEMODIALYSIS
    KONISHI, K
    OZAWA, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) : 647 - 651
  • [26] PHARMACOKINETICS OF SULBACTAM AMPICILLIN IN HUMANS AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION
    RIPA, S
    FERRANTE, L
    PRENNA, M
    CHEMOTHERAPY, 1990, 36 (03) : 185 - 192
  • [28] Pharmacokinetics of an ampicillin-sulbactam (2:1) combination in turkeys
    Carceles, C. M.
    Fernandez-Varon, E.
    Espuny, A.
    Escudero, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 98 - 98
  • [29] PHARMACOKINETICS OF AMPICILLIN-SULBACTAM IN HEALTHY ELDERLY AND YOUNG VOLUNTEERS
    MEYERS, BR
    WILKINSON, P
    MENDELSON, MH
    WALSH, S
    BOURNAZOS, C
    HIRSCHMAN, SZ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) : 2098 - 2101
  • [30] COMPARATIVE PHARMACOKINETICS OF AMPICILLIN-SULBACTAM COMBINATION IN CALVES AND SHEEP
    MONTESISSA, C
    VILLA, R
    SONZOGNI, O
    BELLOLI, C
    CARLI, S
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (05) : 359 - 364